SCHEMBL15519505

SCHEMBL15519505

O=C1Nc2nc(-c3nn(Cc4ccccc4F)c4ncccc34)ncc2[C]1O

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9914089 0.91 PDE5A (0.65) PDE5A
SCHEMBL9913993 0.89 PDE5A (0.61) PDE5A
SCHEMBL326790 0.89 PDE5A (0.61) PDE5A
SCHEMBL15520223 0.82 PDE5A (0.59) PDE5A
SCHEMBL15519507 0.81 PDE5A (0.65) PDE5A
SCHEMBL9913955 0.81 PDE5A (0.64) PDE5A
SCHEMBL9914064 0.81 PDE5A (0.77) PDE5A
SCHEMBL9913994 0.80 PDE5A (0.77) PDE5A
SCHEMBL9913942 0.80 PDE5A (0.89) PDE5A
SCHEMBL9914178 0.80 PDE5A (0.75) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2708539-A1 Annulated pyrimidines and triazines and their use Bayer Intellectual Property GmbH (DE) 2014-03-19 EP disclosed
EP-2682394-A1 1H-pyrazolo[3,4-b]pyridin-triazine derivatives and their use for the treatment or the prevention of cardiovascular diseases Bayer Intellectual Property GmbH (DE) 2014-01-08 EP disclosed